Daxor Corporation announces the expansion of its blood volume analysis capabilities through its ezBVA Lab service. Daxor will partner with the hospital to provide lab processing of its patient tests, providing a rapid 24-hour testing service that is highly efficient for the hospital to implement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXR:
- Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
- Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time
- Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network
- Daxor announces launch of BVA program at mid-south largest integrated network